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Abstract
Aims: To examine the effectiveness of the current diagnostic and treatment approach of
overactive bladder (OAB) and the relative impact of cognition on what is currently a bladdercentric condition. Methods: A review of the literature on OAB from the population to
organ/brain level was conducted. The impact of age-induced bladder dysfunction via cognitive
changes to sensory integration and attention control are discussed. Results: OAB uses bladdercentric terminology to represent a collection of symptoms with inconsistent and often unknown
pathology. Proposed etiologies and therapeutic models for overactive bladder focus on the
bladder organ, but evidence suggests that age-related degradation to inhibitory neural circuits
and attentional switching mechanisms may enhance myogenic dysfunction or be implicated in
idiopathic diagnoses. There is potential for cognitive-level interventions and research that may
reduce the significant public health burden of OAB and related bladder dysfunctions.
Conclusions: The influence of cognitive dysfunctions on bladder control emerges as a
potentially substantial determinant of population OAB burden.
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Introduction
Our population is aging and projections estimate that by 2030 there will be more adults
over 65 than children under 10 for the first time in world history.1 As people age, chronic
diseases become more prevalent and often present simultaneously, with 62% of Americans over
65 having at least two chronic conditions. 2 Chronic diseases now account for over 87% of the
disease burden in the over-60 population globally and are the most common causes of mortality. 3
The 21st century presents public health with the new challenge of accounting for the
disproportionate ratio of life years to health years. Confronting the burden of disease in the aging
population will prove to be an urgent consideration as the global over-60 population increases to
two billion by 2050.4
Overactive bladder (OAB) is a common urological disorder consisting of urinary urgency
accompanied by urgency incontinence, frequency or nocturia in which no precise cause can be
identified.5 OAB is highly prevalent and imposes significant burden to public health. In the U.S.
adult population, the prevalence of experiencing OAB symptoms at least “sometimes” is 27.2%
and 43.1% for men and women respectively.6 It is predicted that 41.9 million people in the U.S.
will be affected by OAB in 2020, up from 34 million in 2007. 7 It can impact people of any age
and it is estimated to affect up to 50% of adults over 75.6 The number of those suffering with
OAB will rise as the aging population is increasing on a scale unparalleled in human history.
Bladder dysfunction is not only ubiquitous but can be exceedingly bothersome. It is
estimated that 65% of people with OAB report their condition having an effect on their daily
life.8 Longitudinal studies of OAB suggest that it is a chronic condition and that symptom
prevalence and severity tends to increase with age. 9,10 Increasing severity is also associated with
decreasing health related quality of life (HRQoL) physical and mental health scores. 9,11 Bladder
1

dysfunction may account for population-level trends in HRQoL seen in aging adults. Those who
suffer with OAB report feeling isolated and hopeless and have higher levels of fatigue,
depression, anxiety, and suicidal ideation. 12-15 They are at risk for early retirement,
unemployment, and comorbid conditions, threatening physical and economic public health.16-18
The cost and impact on quality of life are comparable to that of other chronic diseases. 7,19 The
effect of moderate bladder dysfunction on quality of life is similar to having diabetes, high blood
pressure, or cancer; and the effect of severe bladder dysfunction is similar to having a heart
attack or stroke.20 There are also enormous societal costs associated with OAB. In 2020, annual
per capita and total national costs of OAB are predicted to be $1,969 and $82.6 billion

respectively, including the costs of related diagnostic tests, treatments, long-term care and
sanitary products.7 Indirect costs, including missed work due to OAB and disability also
significantly impact the population. Yet despite extensive research, the etiology and natural
history of OAB remain a mystery. 21
Specific Aims
OAB has a major impact on public health, however it presents as a diverse
symptomology with numerous etiologies and inconsistent treatment. This paper questions the
ability of the term OAB to sufficiently capture the complexity and heterogeneity of this condition
at the individual or population level from the perspective of clinical diagnosis, contributing
factors and treatment. An inadequate term does not contribute to precise diagnosis, deterring
thorough treatment. An inadequate term also obstructs appropriate research, specifically in the
area of cognitive control. Current OAB theories revolve around the bladder organ, yet there is
evidence that investing research into the relationship between the brain and the bladder could
reveal pathways for intervention and ameliorating OAB symptoms.

2

Therefore, I suggest the following hypotheses:
Hypothesis 1: Defining OAB based on symptomology alone is an ineffective strategy for
characterizing an idiopathic chronic condition.
Hypothesis 2: There is a failure of linkage between symptoms and function in the current
OAB disease model. OAB etiology changes with age and overlaps with other urinary symptom
complexes, suggesting an underlying age-related condition uncorrelated with symptoms.
Hypothesis 3: Overactivity of the bladder organ itself is augmented by the underactivity
of cognitive control; suggesting OAB dysfunction does not originate solely from the bladder as
the name implies.
A paradigm shift from bladder-centric to cognitive-inclusive brings into question the term
OAB, the relative impact of neural control, the influence of aging, and proposed treatments. The
results of this hypothesis paper will encourage future research into the effect of cognitive decline
on attentional mechanisms affecting bladder control.
Background
Chronic Disease Perspective
Chronic diseases pose a novel threat to global health as lifestyles change and people live
longer. Compared to infectious diseases, which historically represented the greatest danger to
morbidity and mortality, chronic diseases tend to be a result of life-long lifestyle decisions,
impacting an individual holistically on a multi-system level. Medicine has historically
understood disease on the organ level, or smaller, assuming that organ systems function
independently. However, the human body relies on system unison and larger networks to
function. Aging physiology is affected by a broadening of the network of pathology in the body,
confounded by multiple chronic conditions and decline in function. 22 Age is the greatest risk
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factor for almost every major cause of morbidity and mortality in developed nations. 23 Diseases
related to aging are complex, highly interrelated with other pathology, and originate on the larger
system level.24 Geriatric conditions do not adhere to the conventional organ and discipline
boundaries of medicine, proving a challenge to diagnose and treat. 25
This interrelatedness of aging conditions suggests that there are causal commonalities
across the spectrum of those diseases. Geroscience is a new interdisciplinary field of research
that seeks to determine the underlying mechanisms that link aging to chronic diseases to create
prevention strategies for multiple diseases at once. 26 The name “overactive bladder” reflects the
traditional but now antiquated medical tradition of pinpointing a specific organ as the hallmark
of a condition. OAB is an oversimplified term assigned to a complex and multi-system problem.
Most medicines target the bladder detrusor muscle, reducing the afferent signals it sends or
paralyzing the muscle itself. 27 However, the symptoms cannot be neatly tied together and
treatments are only effective for a minority of patients.28,29 It is crucial to understand chronic
conditions such as OAB on the system level, from a geroscience approach. I propose that the
term OAB is still clouded by an outdated understanding of symptom linkage to function that
excludes the possibility for a cognitive relationship. Thus, there is a need to examine OAB from
an interprofessional perspective to comprehend the complexities of this chronic conditions.
History of Terminology
OAB is defined as a complex of symptoms with no presumed predisposing or causative
pathological conditions or infections.5 Although multiple pathologies increase risk of OAB, the
link between symptoms and pathology is not clear.30 Urinary urgency, incontinence, frequency
and nocturia tend to present simultaneously.31 This pattern of co-occurring symptoms involved in
bladder control without a reliable biomarker led to creation of the term OAB to unify them under

4

one diagnosis. The term OAB has only come into popular use within the last couple decades;
first appearing in the literature in 1989 and reaching popularity in 1997.32,33 In 1998 the U.S.
FDA approved medication for patient-reported OAB symptoms, when previously it could only
be prescribed to dysfunction confirmed by urodynamics. Patients could then report their own
symptoms and receive treatment without needing medical tests.34 In 2002 the International
Continence Society defined OAB as “urinary urgency with or without urgency urinary
incontinence (UUI), usually accompanied by frequency and nocturia, in the absence of urinary
tract infection (UTI) or other obvious pathology”. Urgency is defined as “sudden, compelling
desire to pass urine that is difficult to defer”.5 This development brought incontinence care into
the realm of the primary care provider and helped raise public awareness of this traditionally
neglected problem. At the same time, a number of unintended consequences also followed the
use of this tidy OAB definition. It quickly oversimplified a complex constellation of symptoms.
Pharmaceutical companies profited from the simplification of the problem by assigning easily
understood medical solutions.34 In an attempt to understand and treat patients suffering from
OAB symptoms, the creation of the term inadvertently reduced the need to understand the
etiology of individual symptoms.
The ICS definition uses vague terminology such as “with or without” and “usually” and
fails to define what might constitute “other obvious pathology”. 5 Throughout the years, the
definition has been interpreted differently depending on the researcher.30 Epidemiologic research
specific to OAB was inconsistent before the ICS definition in 2002. Slight differences in
interpretation and use of the definition have caused broad variations in study outcome. There are
some controversies in the understanding of the ICS definitions. Nocturia is defined as waking at
night “one or more times to void”, preceded and followed by sleep.5 Many experts believe that
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one void at night should not be considered nocturia, and many studies therefore also use a
definition of at least two voids.8,18,35 Urgency is the subjective complaint of a “sudden
compelling desire to pass urine that is difficult to defer” and many patients have trouble
distinguishing this clinical symptom from normal urges.36 There have been proven difficulties of
understanding OAB symptoms through questionnaires, with people misinterpreting questions
and answering differently in subsequent interviews.37 Due to different definitions of symptoms,
different study objectives, and different methods of measurements, research studies often get results
that cannot be compared.38 The EPIC study used the 2002 ICS definition of nocturia as at least one
nocturnal void per night and found high prevalence (49% men; 55% women). 18 When nocturia was
defined as two or more void per night, the prevalence rates were reduced substantially (21% men;
24% women).18 The EpiLUTS survey used a definition with symptoms occurring “sometimes” and
subsequently “often” and found overall OAB prevalence of 36% and 25% respectively. 39 Experts
disagree on the definition of the OAB condition, and subsequently on the evaluation of patients and
requirements for diagnosis.40 Although there is an agreement that OAB is a chronic condition with
inconsistent symptoms and no cure; there must also be a consensus on terms so as not to confuse
future research and inhibit the public health response. 40 The definitions of any disease and disease
process impact all aspects of patient care. How we define a disease frames the diagnosis
requirements, proposed management, scale of outcomes measured, and research potential.

Methods
Several procedures were followed for the completion of this narrative review and hypothesis
paper. Hypothesis formulation was generated from an extensive literature review to examine the gaps
in the literature and direction of prospective research. The literature review was conducted using
UConn Health Library database searches with keywords including “overactive bladder”
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“incontinence” “urgency” “prevalence” “age” “quality of life” “health care-seeking” “brain or
neural*bladder”. Only English language papers were reviewed. The literature was analyzed using the
software TagNotate, where each article was annotated using tags related to OAB experience and
physiology. In total 124 tags were created to organize themes uncovered in literature (e.g.
incontinence subtypes, lower urinary tract symptoms, study designs, etc.). The tags also labeled
details within those topics (e.g. SUI, MUI, UUI; urgency, frequency, nocturia; longitudinal, metaanalysis, case-control, etc.) directly in the papers to be easily pulled up with critical sections
highlighted. This process created a personalized database with literature easily accessible to clearly
discern overarching themes and define the shortcomings of the available information. I
communicated with experts in the urology, aging, and cognition fields to confirm I had the most up
to date research and receive guidance on clinical perspectives. To elucidate my hypothesis goals, I
created stratifications of OAB experience by age and of OAB compared to UAB. Relevant themes to
stratify by were determined by available data from my review that best represented the condition.
Analysis of the review results was done by drawing together information about history, prevalence,
stratification, impact, assumed pathology, and making conclusions about areas of study that have yet
to be understood.

Results
Hypothesis 1: Ineffectiveness of Characterizing OAB with Bladder-Centric Symptomology
Public health should focus attention toward improving health conditions of most at-risk
populations. For OAB, aging adults represent a vulnerable population due to high prevalence and
severity of co-morbid diseases and conditions among older adults with OAB and other bladder
dysfunctions. Prevalence and severity tends to increase over time with OAB without
incontinence tending to precede OAB with incontinence.9,10 Those with OAB report worse
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HRQoL compared with those without OAB.9 OAB is unique in that it is not life-threatening but
imposes an impact on mental and physical HRQoL similar to other life-threatening conditions.41
The current disease model of OAB leaves a large portion of the aging population
untreated and at risk of poor health. Many older adults with OAB and incontinence do not seek
help despite symptom severity.42 Often they demonstrate a lack of understanding about
symptoms and treatments or consider bladder symptoms to be a normal consequence of aging.
12,43,44

This lack of understanding leads to disappointment in treatment outcome.44 Symptom

bother also tends to be higher in patients who are uncertain about their urinary symptom etiology
or disease course. 45 Holding this confused perspective about OAB and other chronic diseases
paints it as inevitable, and incurable in the mind of the patient, reducing their likelihood to seek
help.37,44 Presently, only 66% of women with OAB think it is a medical condition, and far fewer
know that there are treatments available. 46,47 Treatment-seeking patients are only representative
of a fragment of the population who suffer from OAB, but of those who are diagnosed with
OAB, 76% continue to live with untreated symptoms.48 Although they could have benefited from
treatment, the majority of OAB sufferers are isolated in determining their coping strategies and
experience diminished QoL.4949 It is crucial that older adults seek help for their condition.
Confusion about the symptom etiology is one impediment to effectively reducing disease
burden with the current bladder-centric paradigm and can lead to harmful cultural ideas about the
disease. Bladder dysfunction and incontinence are often perceived as a “retreat to infancy” and
universal symptoms of social incompetence and disgust, promulgating stigma.12,50,51As a result,
only 46% of those with OAB consult a doctor about their symptoms.52 Different cultural ideas
about OAB stigma lead to many of the disparities seen in health seeking behaviors.53 If they do
seek treatment, women wait on average 3.1 years before consulting a physician about OAB
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symptoms.49 Undiagnosed OAB, as a result of stigma and embarrassment, leaves many without
an identity as a patient or an explanation for their behaviors, often resulting in even greater
psychological costs.12 OAB patients suffer without a known etiology, often encouraging selfblame and the idea that symptoms are a result of psychological weakness. 37 Submitting to the
condition as an “old people disease” leads to poor QoL and various detrimental coping strategies,
including withdrawal and resignation.12 Shame related to OAB increases the number of older
adults implementing coping mechanisms such as using sanitary protection, staying home from
work, and avoiding family and friends to evade leakages and embarrassment.37 These strategies
often lead to isolation and depression, and may postpone necessary health care-seeking.12,54
A lack of clarity about OAB etiology coupled with the resulting cultural stigma makes
treatment a complicated process for patients and their physicians. Reluctance of the patient to
disclose their symptoms to their physician is an initial impediment to treatment. The gap between
OAB symptomatology and healthcare-seeking behaviors poses a critical public health threat. If
physicians then share their perspective that OAB is normal aging and not worth investigating as
many do, even fewer OAB patients find useful treatment. Lack of information and support from
medical professionals leads to undertreated populations.44 Although OAB is not curable,
treatment gives people an identity as a patient that helps normalize the condition.12
Despite the related stigma for OAB sufferers, physicians are nine times less likely to
bring up bladder concerns than patients.55 Studies show that physicians also insufficiently
address the impact of OAB on QoL when discussing the condition with patients. 56 OAB patients
are often dissatisfied with their care and many believe that their doctors do not take their
experience seriously.53 Although clinical dialogue regarding OAB is physician-centered,
research shows that patient-centered communication (PCC) is correlated with more effective
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management of OAB.56 In 2001, the Institute of Medicine identified PCC as a key aspect of
high‐quality healthcare and it has since become an increasingly important part of the research
and healthcare lexicon. 57 The movement towards PCC internationally will impact the way the
medical world views OAB. Despite all the research, very few initiatives directly increase
physician attention to lower urinary tract symptoms (LUTS).
Without reliable healthcare seeking, population prevalence of OAB can’t be estimated
from medical records, adding complexity to epidemiological studies. It is essential that these
studies reveal the magnitude of the population burden, yet due to inconsistent research methods
and study terms, the results differ broadly. Consequently, medical centers and epidemiologists
only see “the tip of the urological iceberg,” which is what makes it such an interesting and
complicated topic.58 Using bladder-centric terminology, therapeutic practices, and research might
leave susceptible individuals without a course of prevention or remedial action. Living with a
vague diagnosis of OAB and lack of a cure is associated with significant bother that increases
with age.52
Hypothesis 2: Failure of Linkage of Symptoms to Function
Diagnosing techniques
Appropriate diagnoses are crucial for reducing population burden, but without a firm
understanding of pathology attempting accurate and precise diagnoses may be ineffective.
Bladder dysfunction can be diagnosed by invasive tests called urodynamics studies (UDS), but as
a symptom complex, patients can identify themselves as having OAB thus forgoing the need to
invest the time into an invasive diagnosis. Clinical algorithms for treating OAB use patient report
to diagnose OAB and often reserve UDS for failures in treatments.30 OAB is considered a
problem with the detrusor muscle and UDS is a method for diagnosing detrusor overactivity
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(DO). However, LUTS were recognized as poor predictors for urodynamic function long before
the use of the term OAB.59 Only 54-64% of patients with OAB have urodynamic results proving
DO 60,61 Inversely only 82% of patients with DO have symptoms suggestive of OAB.61 When
DO is accurately identified as the source of OAB symptoms, the DO may not persist over time
despite the persistence of symptoms.62 The incidence of persistent DO after 5 years is only
57%.62 OAB is a chronic condition, yet often follows a pattern of incidence and remission.38
Despite all the clinical focus on the bladder as the source of dysfunction, it often proves
an unreliable witness to underlying OAB conditions. This phenomenon highlights the disparity
between symptoms and function. It explains how challenging it can be to effectively treat OAB
based on symptoms or proven dysfunction. A bladder-centric model of treating OAB is
insufficient for understanding the multifactorial condition.
Therapies
Although available treatments for OAB patients have vastly improves over the last 50
years, none are entirely curative as underlying disease mechanisms remain mysterious. A limited
understanding of OAB pathogenesis and how it uniquely presents in each patient makes
prescribing treatment challenging. Drug companies stepped into this void of uncertainty and
assigned drugs that aim to reduce symptom burden but fail to address the cause.28 Effective
treatment is determined through trial and error, leaving many patients dissatisfied and
discouraged from continuing any treatment.37 Only 56% of women feel their OAB medication is
effective.44 Most people only spend a few months taking OAB medication before giving up on
them, and some even switch medication many times before quitting. 37
In the absence of reliable UDS testing, OAB patients are often incorrectly assigned
anticholinergics, particularly antimuscarinics. Antimuscarinics bind to receptors on the bladder
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muscle in order to block the input sent to contract the muscle.27 These drugs reduce the intensity
of involuntary bladder contractions that can cause urgency and leakage. Unfortunately,
muscarinic receptors exist all throughout the body and many antimuscarinic drugs are nonspecific, affecting other processes and causing bothersome side effects such as dry mouth and
constipation.30 These drugs may promote more harm than good to many patients, especially
among older populations. The treatment of older adults with bladder antimuscarinics is also
being called into question due to a significant association with cognitive decline and an increased
risk of cardiovascular disease and mortality.63,64,65 Anticholinergics are the most common
prescribed medication for OAB, but only perform modestly better than placebos.28
Medicinal therapy is more effective when initiated in conjunction with behavioral
interventions such as fluid management, avoidance of caffeine and alcohol, bladder retraining,
and double voiding and should be used as a first line of treatment.30,66 Patients using behavioral
modifications report equal or superior QoL and are less bothered by their symptoms than patients
using standard care.30 One study showed that among those using behavioral management
strategies UI severity decreased by 61% after two years while the control group severity
increased by 184%.67
Therapies which focus solely on myogenic dysfunction of the lower urinary tract can
result in inadequate and unreliable outcomes since OAB symptoms do not indicate one single
disease. The lack of consistent pathology, symptom presentation, and treatment for a condition
under a single diagnosis for all patients may promote frustration. Frequency, urgency, urge
incontinence, and nocturia are caused by numerous pathologies.28 Rather than lumping together a
group of symptoms, individual symptoms should be investigated separately to understand their
individual risk factors and underlying pathophysiology. Also, encouraging the opinion that
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symptoms, however mild, are part of a single medical syndrome risks overmedicalization.
Approaching OAB examinations and research from different angles will provide insight into the
multifactorial nature of this chronic condition. The relationships between risk factors, neural
pathways and bladder outcomes are only just beginning to be understood and will reduce future
OAB public health burden. Moving toward effective treatment of symptoms through recognizing
individual patient history and pathologic conditions will require abandoning the antiquated
concept of an OAB symptom complex or a bladder-centric condition.
Stratifications to Represent Failure of Linkage of Symptoms to Function
Numerous studies have examined the experience of OAB on the individual and
population level, yet the etiology remains complex and not well understood. The suggestion of a
single clinical entity for OAB symptoms implies that there is a singular etiology and a uniform
treatment when in fact similar symptoms may present bother as a result of different disease
processes. UI and OAB, along with other LUTS, are associated with numerous comorbidities,
suggesting shared etiologies and further complicating the relationship between function and
symptoms.68 There is also agreement among experts that the pathophysiology of OAB is
incompletely characterized because of the diversity of experiences across the patient spectrum.40
Some experts suggest that OAB experiences should be phenotyped, but that does not come
without its difficulties. 69 To further illustrate the failure of the term OAB to represent a singular
consistent entity and question the focus on the bladder organ, we can examine the experience
stratified by age (Table 1) as well as compared to similar diagnoses (Table 2).
(1) Age Stratification
The age-dependent nature of OAB suggests that bladder dysfunction and related
comorbidities are determined by aging. In older patients, the condition becomes a geriatric

13

syndrome; having multifactorial etiology and substantially impacting quality of life. 25 An
association of storage, voiding, and incontinence symptoms with conditions increasingly
common in older adults, including diabetes, hypertension, depression, and constipation, further
influences clinical presentation and outcomes, compounding the impact of urinary symptoms on
life quality in older adults. 70 Aging is characterized by general degradation in homeostatic
mechanisms in the body.25 Homeostasis is the maintenance of numerous mechanisms with an
aggregate effect of sustaining consistency in physiologic conditions regardless of external
influences. As homeostatic regulation is impaired with aging, the capacity to respond
appropriately to various challenges is diminished.25 It can be a challenge to determine the
relative effect of aging in older populations when considering the increasing impact of chronic
conditions as both may share biological pathways.26 In order to relate symptoms to dysfunction
in an aging patient, there must be a causal understanding of how aging impacts bladder control.
The term OAB makes this connection difficult, implying that the dysfunction resulting in the
symptoms is DO rather than underactive control of the brain mechanisms that maintain
homeostasis in healthy adults. Evidence from the age-dependent nature and neural control of
OAB suggests that the current therapeutic model and terminology highlighting detrusor over
activity overlooks the important function of cognitive control, conscious or unconscious.
Understanding how physiological mechanisms change with age is critical to the development of
appropriate diagnoses and treatments, particularly in today’s rapidly aging society. The
representation of OAB across the spectrum of age in Table 1 reveals the failure of the term OAB
to represent the varying etiologies and symptom outcomes.
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Table 1: Stratification of OAB Prevalence, Comorbidity, Bother, and Health Care-Seeking
by Age
Age

40-44

Population
Prevalence of
OAB from
EPIC18
(extrapolated
from graphs)
• 8% men
• 11% women

Population
Prevalence of
OAB from
EpiLUTS6

Sometimes
• 17% men
• 37% women

Population
Prevalence of
OAB from
NOBLE71
(extrapolated
from graphs)
• 12-18% men
10-22%
women

Population
Prevalence
Comorbidities72

Population Prevalence
of Bother from
Urgency
(extrapolated from
graphs)

Prevalence of
Health CareSeeking in OAB
Population52

•

Men 30-4973
• Small bother: 17%
• Moderate bother:
4%
• Severe bother: 1%

•
•

24-33% men
27-36%
women

•
•

33-46% men
36-52%
women

•
•

58-62% men
54-57%
women

18% have
multiple
chronic
conditions

Usually
• 8% men
• 26% women

45-64

•
•

8-15% men
11-16%
women

Sometimes
• 21-34% men
• 41-47%
women

Women 40-5074
• Any bother: 28%
• Moderate-severe:
10.6%
•
•

18-26% men
22-23%
women

•

51% have
multiple
chronic
conditions

Usually
• 10-20% men
• 29-37%
women

>65

•
•

16-23% men
15-20%
women

Sometimes
• 34-50% men
• 45-51%
women
Usually
• 20-35% men
• 36-43%
women

Men 50-6973
• Small bother: 32%
• Moderate bother:
9%
• Severe bother: 3%
Women 50-6074
• Any bother: 42%
• Moderatesevere:15%

•
•

30-35% men
30-32%
women

•

82% have
multiple
chronic
conditions

Men 70-8973
• Small bother: 40%
• Moderate bother:
14%
• Severe bother: 6%
Women 60-80+74
• Any bother: 4659%
• Moderatesevere:19-31%

OAB=Overactive bladder, EPIC= European Prospective Investigation into Cancer and Nutrition,
EpiLUTS= Epidemiology of Lower Urinary Tract Symptoms, NOBLE= The National Overactive Bladder
Evaluation
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Table 1 provides a description of studies that examine OAB by age. Most OAB studies
do not stratify by comparable age groups, use consistent definitions, or research similar
populations. Therefore, stratification is limited to a small number of studies, but trends can still
be seen across the existing data. EPIC, EpiLUTS, and NOBLE studies were chosen for
prevalence stratification by age for their large population size, ICS definition, and relatively
comparable age groups. These studies show how prevalence increases with age in both genders.
These aging populations also experience comorbidities that can impact HRQoL and influence the
OAB disease experience. Related to an increasing severity, health care-seeking also increases
among those with OAB with age. These stratifications represent a few elements of the OAB
experience that diversify the diagnosis. Older adults experience a geriatric syndrome, related to
other chronic conditions, with a potential underlying age-related cause.
There are also stratifications that aren’t represented in Table 1. While symptom bother
was reported by 54% of those with OAB, subgroups within the OAB population experience
symptom severity and bother at widely varying degrees.75 Those with OAB-wet (with UI)
experience more bother than those with OAB-dry.75 Further, although women are more likely to
experience UI, significantly more men with UI reported bother than women with UI. 75 UI is
presented differently by age as well, with older groups experiencing more urge urinary
incontinence (UUI) and younger groups experiencing more stress urinary incontinence (SUI). 76
There are also race and ethnic differences in prevalence and health beliefs related to LUTS and
OAB that determine burden and healthcare seeking.44 Healthcare seeking is confounded by
factors such as social influences and connectivity to others with similar symptoms that is
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associated with both age and symptom severity. 77 It is also not rare that studies contradict each
other in their results.
(2) Stratification by Condition
Just as age stratification demonstrates the lack of a single pathology and undermines the
use of the term OAB, comparing OAB to another bladder symptom complex, UAB (underactive
bladder), exposes the potential for a unifying pathology external to the bladder influencing the
expression of symptoms. The similarities shown in Table 2 between OAB and UAB demonstrate
how the brain-bladder axis effects bladder dysfunction. While OAB is the more widely
acknowledged of the two, both have an unknown or inconsistent etiology and arise from an
impairment of the micturition reflex, whether on the myogenic or neurogenic level. An impaired
sensory integration and therefore compromised neural control mechanism could account for both
directions of dysfunctional control (over or under). I hypothesize that overactive bladder is
associated with underactive neural control of the bladder and suggest the brain might be a better
witness to the source of urinary dysfunction than the bladder.
Table 2. Comparison of OAB and UAB
OAB
Dysfunction •
•
•

•

Lack of neural
inhibition78
Detrusor overactivity in
some cases61
May be caused by
increased efferent
signals from the brain to
the bladder78
May be caused by
increased afferent
signals from the bladder
to the brain79,80

Similarities

UAB

•
•

•

•

Associated with aging30,81
Unknown/inconsistent/idiopathic
etiology30,82
Impairment of the micturition reflex78
o Myogenic
▪ Age-related bladder
changes83
▪ Abnormalities of the
urothelium, interstitial cells,
ganglia and smooth muscle
cells that activate afferent
nerve fibers84,85
o Neurogenic
▪ Nervous system
dysfunction86,87

•
•
•
•

Detrusor underactivity in
some cases90
May be caused by decreased
efferent signals from the
brain to the bladder85,91
Can be due to chronic
obstructive or neurologic
damage92
May be cause by decreased
sensitivity of the bladder91
May be caused by decreased
afferent signals from the
bladder to the brain79,,
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▪

Symptoms

•

•
•

Urgency with or without
urge incontinence,
usually with increased
frequency and nocturia5
May have overactive
detrusor61
Distinguished by
urgency5

•

•
•
•

•

Failure of integration or
processing in neural circuits78
• Dysfunction of neural
bladder control
mechanisms 88
• Dysfunction of attentional
switching mechanisms 89

Symptom complexes with shared
symptoms including frequency, urgency,
and nocturia and can include
incontinence 5,82
Diminished sense of when the bladder is
full
decreased control over bladder87
Both can occur together—detrusor
hyperreflexia with
impaired contractility (DHIC) 93
OAB may progress to UAB87
Symptoms and severity of UAB vary
from one person to another, and the
course of the disease is often
unpredictable38, 87

•

82

•
•
•
•

Treatment

Experience

Pelvic floor exercises,
delayed voiding,
neuromodulation, antimuscarinics30
• Abundance of research
studies30

A symptom complex
suggestive of detrusor
underactivity which is
usually characterized by
prolonged urination time
with or without a sensation
of incomplete bladder
emptying, usually with
hesitancy, reduced sensation
on filling, and a slow stream
Diminished sense of when
the bladder is full94
May have high residual
urine92
May have underactive
detrusor 90
No single distinguishing
symptom81

Scheduled voiding, bladder diary, dietary
changes30,92

Double voiding, catheterization,
Surgery, muscarinic receptor
agonists92

•

•

•
•
•
•

Challenging to diagnose and treat
o Lack of objective tests and
biomarkers5,82
▪ Does not correlate well with
urodynamics 61,90
o Lack of consensus on terms 40,95
o Therapeutic measures are largely
palliative in nature and associated
with significant morbidities. 30,92
o Often remains undetected and
undertreated 58
o Mechanisms not well-understood 87
Related to stigma, embarrassment, and
reduced QoL12,96
Age dependent 30,92
Affects both genders18,96
Chronic condition 9, 87

Shortage of studies82
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•

Risk factors and common comorbidities:
MS, spinal cord injury, diabetes,
Parkinson’s disease, stroke, dementia,
impaired mobility, UTIs, bladder outlet
obstruction, smoking and obesity 30,97
OAB=Overactive Bladder, UAB=Underactive Bladder

Hypothesis 3: Overactivity of the Bladder and Underactivity of the Brain
Age-Related Changes in Bladder Tissues
Shifting away from a bladder-centric view of OAB does not mean the rejection of
evidence signifying age-related bladder changes. OAB has been associated with observable
alterations to tissues and responsivity as the bladder ages. These changes, including those in the
urothelium, neurotransmitters and receptors, and inflammation levels have all been implicated as
the source of the age-dependent distribution of OAB. 84 First, an increase in collagen content
resulting in urinary fibrosis may be responsible for the decreased bladder compliance seen with
aging.97 Further, the urothelium is a complex organ that receives and transmits information about
the bladder.98 It is possible that age-related reductions in neurotransmitters released from bladder
nerves, including ACh and ATP, might be responsible in part for OAB in aging adults.99 There
are also changes in muscarinic receptors in the bladder associated with normal aging that might
impact bladder function. 100 Inflammation is a new field of research, and elevated inflammation
biomarkers in older adults might be related to overactive bladder.84 Innervation of the bladder
decreases with age in those with OAB, however there is no evidence of declines in detrusor
smooth muscle contractility or excitability as people age. 101 These alterations in the bladder
tissues attributable to age might affect how appropriately the bladder responds to normal efferent
signals or enhance the effect of abnormal signals.
Normal Bladder Reflex Physiology
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It is helpful to move away from a bladder-centric model of OAB to fully understand the
basis for disease. There are impairments to central neural processing that can amplify the agerelated dysfunctions of the bladder and sensory systems. The normal physiology of the brainbladder axis is complex and not fully understood, but existing evidence suggests that OAB may
be a result of underactive control more than overactivity of the bladder. Consistent bladder
control is a result of neural integration of somatic stimulation, autonomic reflexes and high-level
control and decision-making mechanisms about when and where to void.78 The normal
physiology of the bladder is rooted in the neural control of the spinobulbospinal voiding reflex
responsible for switching the system between storage and voiding. 102 The lower urinary tract is
constantly monitored and modulated by the brain in response to afferent information from
bladder wall tension. 103 As the bladder fills in the storage phase, the brainstem’s periaqueductal
gray (PAG) receives afferent signals.78 The PAG sends signals to the pontine micturition center
(PMC) or “Barrington’s Nucleus”, which relaxes the urethral sphincter and causes an involuntary
void.78
Automatic relaxation of the urethral sphincter is speculated to be controlled by three
high-level circuits that conduct sensory, motor, emotional, and cognitive processing to reserve a
voiding behavior for a safe, socially acceptable, and convenient time and place.78,104 The
micturition reflex and control circuits are outlined in Figure 1. The frontal circuit (1) includes the
regions includes the insula, thalamus, lateral prefrontal cortex (lPFC), and medial prefrontal
cortex (mPFC) and is the target of most ascending signals from the PAG.78 78 Sensations from
the bladder are registered in the insula, where the sensory information is put into context.78 With
the goal of maintaining homeostasis, contextualized information from the insula is then used to
make the decision to void or to continue storing. 105 The midcingulate circuit (2) includes the
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supplementary motor area (SMA) and dorsal anterior cingulate cortex (dACC) and serves as a
secondary process in cases of failure by the frontal circuit.78 The ACC determines how to react
to visceral signals from the bladder depending on the situation.103 The dACC triggers activation
of the SMA to activate muscles of the pelvic floor and urethreal sphincter.105 The subcortical
circuit (3) involves the hippocampal and paralimbic regions and serves as a third reinforcement
against incontinence. This circuit evaluates the safety of the voiding behavior and influences
voiding decision-making.103

Figure 1. Model of brain-bladder control. PAG= Periaqueductal Grey, dACC= dorsal anterior
cingulate cortex, lPFC=lateral prefrontal cortex, mPFC=medial prefrontal cortex, ON=Onuf nucleus, Sa=
sacral cord, SMA= supplementary motor area, th=thalamus. From de Groat WC, Griffiths D, Yoshimura
N. Neural control of the lower urinary tract. Compr Physiol 2015;5(1):327–96 78

Age-Related Changes in Neural Control
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Adults without OAB can maintain continence through these inhibitory controls and make
calm decisions about when to void. The dysfunction of these inhibitions, or the underactivity of
control is what this paper proposes to influence the cause of OAB symptoms. OAB patients
exhibit abnormal connections between inhibitory circuits, recruiting accessory circuits involving
the parieto-temporal lobes, parahippocampal gyrus, and cerebellum. 106 Irrespective of the
bladder, there are differences in motor and sensory regions (precentral and postcentral gyrus) as
well as attention (inferior parietal) and decision-making regions (inferior and superior frontal
gyrus) between those with and without OAB. 107
The overall influence of age on the brain is a general decrease of response in all areas,
potentially responsible for the reduced sensory feedback required for bladder control. 108 Brain
responses differ in old and young individuals with OAB despite similar symptoms, reiterating the
earlier point of inconsistent etiology under the same term and exemplifying the potential for
inhibition interruption in older adults.108 When younger adults experience urgency, there are
reduced responses at smaller bladder volumes and exaggerated responses at high volumes. In
older adults, small volumes elicit stronger responses and more modest responses at large
volumes.108 Also, white matter hyperintensities (WMH) are associated with aging, cognitive
impairments and incontinence and might be responsible for decreasing neural connectivity
hindering inhibition circuits.108
The brain normally has the ability to switch attention to address the most immediate
concern or threat to safety. Until an alert from the bladder that it is getting full, attention may not
be focused on the bladder, instead fixing on more pressing matters. There is existing evidence
that suggests that attention is a crucial element of age-related decline in cognitive control of the
bladder. In normal physiology, PMC innervates the bladder neurons as well as the locus
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coeruleus (LC), which in turn activates the cortex increasing arousal to stimuli and shifting
attention.89 Functional MRI studies have demonstrated that the orbitofrontal cortex, involved in
cognitive processing and decision making, is increasingly activated in those with normal bladder
control, but weak among those with OAB regardless of detrusor activity.109 Additionally,
emotional interference in the limbic system might also be implicated in attentional switching.
The insula, ACC, and mPFC become less activated and signals in the frontal and midcingulate
circuits less substantial as people age, reducing the ability to maintain continence regardless of
OAB diagnosis.110 In subjects with OAB, fMRI studies show there is increased activation in the
limbic cortex including the ACC and insula associated with urgency suggesting that urgency
promotes an increased emotional response in those with OAB.109,111 The overwhelming
emotional conflict of potential social embarrassment due to leakage can impair inhibition
processes in those with OAB. 112 Increased emotional response might reduce the ability to switch
focus away from the troubling sensation of a filling bladder, promoting urgency.
Beyond the visceral substantiation, the hypothesis that overactive bladder is primarily
modulated by underactive cognitive control is exemplified by empirical evidence. Older adults
have a harder time multitasking, disengaging from distractions, and switching between focuses
which may be potentially related to the neural integration dysfunctions we see in those with
OAB.113 Urgency can be influenced by circumstances, and often plays tricks on OAB sufferers,
determined by the immediacy of finding a bathroom or having limited competing distractions,
not necessarily signaling a full bladder.12 Those with OAB and incontinence cite common
triggers such as putting the house key in the door and undoing pants in preparation for using the
bathroom that often prompt urgency and leakages.37
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These triggers highlight the influence of inappropriate attentional switching, lack of
conscious control and indicate the influence of what can be called the “forgetful bladder”. The
“forgetful bladder” is part of a complex interaction of aging bladder tissues, sensory networks,
neural integrations and cognitive attentional abilities that may account for a lack or excess of
attention as a result of bladder filling. The cognitive ability to forget a sensation is evolutionarily
beneficial to maintain homeostasis and can allocate appropriate attention to the most pressing
concern, but any imbalance could result in the abnormal storage and voiding symptoms
categorized as OAB.
Discussion
This thesis is an attempt to comprehensively summarize the current literature describing
the condition of OAB and how the sole focus on the bladder is a detriment to public health. OAB
is defined as a condition with no known underlying condition so attempting to understand a
potential cause is part of the effort to decrease disease burden. There is neither established
natural history nor causal understanding of OAB, both of which are vital for effective public
health prevention and control.114 Recent years have seen the major increase in available therapies
for OAB, but none are entirely curative. This situation could be because most research has
focused on the bladder organ as the source of dysfunction. With appropriate causal
understanding and more accurate diagnoses, more focused treatments may be assigned.
The proposal to invest research into the cognitive control of the bladder is a result of a
literature review and the determination of gaps in current knowledge. Piecing together literature
that approaches OAB from many different angles brought me to the synthesis of my hypothesis
that the urgency sensation that is a hallmark of OAB may be a product of the brain’s diminished
ability to administer appropriate attentional focus to physiological changes as a result of aging.
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These attentional errors related to both aging and OAB may be compounded by age-related
changes at the bladder level. There may be heightened amount of sensory information being sent
to the brain encouraging the higher processes to immediately seek a place to void at lower
volumes or the decreased sensitivity to the sensory information being sent from the bladder
producing an insufficient reaction to the filling bladder until urgency is the only option (cite
both). The underactivity of cognitive control of the bladder may also prove to be the dysfunction
influencing idiopathic OAB, UAB, or other urinary control symptoms.
The available literature is written from a variety of professional perspectives including
epidemiological, clinical, and experimental. Examining all of it together highlights the need for
future research to merge disciplinary silos. Chronic diseases like OAB affect the individual
across the spectrum of the social-ecological model: genetic and lifestyle risk factors can generate
numerous dysfunctions that may interact to present a variety of symptoms, interpersonal
relationships with health care providers may determine treatments, and societal norms may
influence stigma and care-seeking behaviors. This hypothesis paper attempts to emphasize how
interprofessional research may reveal OAB dysfunction and an effort was made to include
research taking diverse approaches. However, this broad goal of understanding all angles may
also be a limitation, as the review could not be systematically focused around a single element of
OAB literature.
Conclusion
Today’s aging population is continually increasing the number at risk for chronic
conditions. OAB is a common condition that poses a considerable threat to quality of life, but
few effective therapeutic measures are available. Advancing age is implicated as the greatest risk
factor for incidence and severity of OAB, and special attention should be paid to the bladder
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symptoms of the aging population. This thesis summarizes how OAB is a symptom complex
with vague terminology representing a variety of co-occurring LUTS. By synthesizing the
literature, this paper aims to illuminate how the bladder-centric nature of OAB terms is
misleading. The first hypothesis was that this classification of OAB negatively impacts public
health. Secondly, this review hypothesized that there is a potential for underlying age-related
conditions separate from the bladder. Remarking on the failure of linkage from symptoms to
function, this hypothesis is expressed by stratifying prevalence and experience by age and
displaying similarities across bladder control conditions. When OAB is compared to UAB,
sensory integration and control malfunction arises as a commonality between the two conditions,
accounting for the unique symptoms of each complex. The bladder is part of a complex network
involving neural control systems that are affected by age. The analysis of existing research leads
to the third hypothesis that the cognitive and attentional deficits of sensory integration in an
aging brain directly impact the overactive bladder. Information synthesized in this thesis
suggests that a more thorough understanding of the attentional mechanisms could encourage new
management strategies.
Investment into research on cognition and bladder control would require a paradigm
switch from a bladder-centric view of OAB to include the possibility for neural integration
dysfunction. The fact that at least half of urgency and leakage episodes vanish when using
mindful urge suppression strategies alone is convincing evidence for the power of the brain over
the bladder and suggests that cognitive circuits are a useful target for OAB therapies.115 Future
research should describe the relative contributions of motor, sensory, biomechanical, and
cognitive dysfunctions to bladder function associated with aging. To understand the effect of
emotional or cognitive function on urgency and bladder dysfunction researchers should combine
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brain-scanning and urodynamic practices while performing distracting or emotional tasks. If
cognitive function is found to be substantially linked to urgency in older adults, researchers can
assume that bladder sensations might be sufficiently distracting to hinder performance of
previously achievable tasks such as driving.
Public health professionals can advocate for this perspective change as it might result in
more helpful diagnosing techniques when patient history suggests age-related cognitive decline,
thus reducing the population suffering without a cure for OAB. Recognizing the failure of the
term OAB to represent dysfunction and improve health, and subsequently investigating the role
of cognition in bladder control could reduce chronic disease burden in the older adult population,
improving health-years as life-years are continuously extended.

27

Citations
1

United Nations, Department of Economic and Social Affairs, Population Division (2017).
World Population Ageing 2017 – Highlights. 2017. ST/ESA/SER.A/397.
2

Ward BW, Schiller JS. Prevalence of multiple chronic conditions among US adults: estimates
from the National Health Interview Survey 2010. Prev Chronic Dis. 2013;10(65).
doi:10.5888/pcd10.120203
3

NIH, U.S. Department of State. Why Population Aging Matters: A Global Perspective. An
Aging World: 2015.; 2007.
4

UNFPA and HelpAge International. Ageing in the Twenty-First Century: A Celebration and a
Challenge. New York: United Nations Population Fund (UNFPA); 2012.
5

Abrams P. Describing bladder storage function: overactive bladder syndrome and detrusor
overactivity. Urology. 2003;62(5):28-37. doi:10.1016/j.urology.2003.09.050
6

Coyne KS, Sexton CC, Vats V, Thompson C, Kopp ZS, Milsom I. National Community
Prevalence of Overactive Bladder in the United States Stratified by Sex and Age. Urology.
2011;77(5):1081-1087. doi:10.1016/j.urology.2010.08.039
7

Ganz ML, Smalarz AM, Krupski TL, et al. Economic costs of overactive bladder in the united
states. Urology. 2010;75(3):526-32, 532.e1-18. doi: 10.1016/j.urology.2009.06.096
8

Milsom I, Abrams P, Cardozo L, Roberts R, Thüroff J, Wein A. How widespread are the
symptoms of an overactive bladder and how are they managed? A population-based prevalence
study. BJU International. 2002;87(9):760-766. doi:10.1046/j.1464-410x.2001.02228.x
9

Malmsten UG, Molander U, Peeker R, Irwin DE, Milsom I. Urinary Incontinence, Overactive
Bladder, and Other Lower Urinary Tract Symptoms: A Longitudinal Population-Based Survey in
Men Aged 45–103 Years. European Urology. 2010;58(1):149-156.
doi:10.1016/j.eururo.2010.03.014
10

Wennberg A-L, Molander U, Fall M, Edlund C, Peeker R, Milsom I. A Longitudinal
Population-based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary

28

Tract Symptoms in Women. European Urology. 2009;55(4):783-791.
doi:10.1016/j.eururo.2009.01.007
11

Lee K-S, Yoo TK, Liao L, et al. Association of lower urinary tract symptoms and OAB
severity with quality of life and mental health in China, Taiwan and South Korea: results from a
cross-sectional, population-based study. BMC Urology. 2017;17(1). doi:10.1186/s12894-0170294-3
Nicolson P, Kopp Z, Chapple CR, Kelleher C. It’s just the worry about not being able to
control it! A qualitative study of living with overactive bladder. British Journal of Health
Psychology. 2008;13(2):343-359. doi:10.1348/135910707x187786
12

13

Ge TJ, Vetter J, Lai HH. Sleep Disturbance and Fatigue Are Associated With More Severe
Urinary Incontinence and Overactive Bladder Symptoms. Urology. 2017;109:67-73.
doi:10.1016/j.urology.2017.07.039
14

Breyer BN, Kenfield SA, Blaschko SD, Erickson BA. The Association of Lower Urinary Tract
Symptoms, Depression and Suicidal Ideation: Data from the 2005–2006 and 2007–2008 National
Health and Nutrition Examination Survey. Journal of Urology. 2014;191(5):1333-1339.
doi:10.1016/j.juro.2013.12.012
15

Kinsey D, Pretorius S, Glover L, Alexander T. The psychological impact of overactive
bladder: A systematic review. Journal of Health Psychology. 2014;21(1):69-81.
doi:10.1177/1359105314522084
16

Tannenbaum C, Gray M, Hoffstetter S, Cardozo L. Comorbidities associated with bladder
dysfunction. International Journal of Clinical Practice. 2013;67(2):105-113.
doi:10.1111/ijcp.12085
17

Coyne KS, Sexton CC, Thompson CL, et al. Impact of Overactive Bladder on Work
Productivity. Urology. 2012;80(1):97-103. doi:10.1016/j.urology.2012.03.039
18

Irwin DE, Milsom I, Hunskaar S, et al. Population-Based Survey of Urinary Incontinence,
Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the
EPIC Study. European Urology. 2006;50(6):1306-1315. doi:10.1016/j.eururo.2006.09.019
19

Welch G, Weinger K, Barry MJ. Quality-of-life impact of lower urinary tract symptom
severity: Results from the health professionals follow-up study. Urology. 2002;59(2):245-250.
doi:S0090429501015060
20

Robertson C, Link CL, Onel E, et al. The impact of lower urinary tract symptoms and
comorbidities on quality of life: The BACH and UREPIK studies. BJU Int. 2007;99(2):347-354.
doi: BJU6609

29

21

Lukacz ES, Sampselle C, Gray M, et al. A healthy bladder: a consensus
statement. International Journal of Clinical Practice. 2011;65(10):1026-1036.
doi:10.1111/j.1742-1241.2011.02763.x
22

Jaul E, Barron J. Age-Related Diseases and Clinical and Public Health Implications for the
85 Years Old and Over Population. Frontiers in Public Health. 2017;5.
doi:10.3389/fpubh.2017.00335
23

Kaeberlein M. Longevity and aging. F1000Prime Reports. 2013;5. doi:10.12703/p5-5

24

Franceschi C, Garagnani P, Morsiani C, et al. The Continuum of Aging and Age-Related
Diseases: Common Mechanisms but Different Rates. Frontiers in Medicine. 2018;5.
doi:10.3389/fmed.2018.00061
25

Kuchel G. Chapter 45: Aging and Homeostatic Regulation. In:Hazzard's Geriatric Medicine
and Gerontology. 7th ed. McGraw-Hill Education; 2017.
26

Kennedy BK, Berger SL, Brunet A, et al. Geroscience: Linking Aging to Chronic
Disease. Cell. 2014;159(4):709-713. doi:10.1016/j.cell.2014.10.039
27

Hartmann KE, McPheeters ML, Biller DH, et al. Treatment of overactive bladder in
women. Evid Rep Technol Assess (Full Rep). 2009;(187)(187):1-120, v.
28

Madersbacher H. Overactive Bladder: A Clinical Entity or a Marketing Hype? European
Urology. 2005;47(3):273-276. doi:10.1016/j.eururo.2004.10.015
29

Reynolds WS, Mcpheeters M, Blume J, et al. Comparative Effectiveness of Anticholinergic
Therapy for Overactive Bladder in Women. Obstetrics & Gynecology. 2015;125(6):1423-1432.
doi:10.1097/aog.0000000000000851
30

Corcos J, Przydacz M, Campeau L, et al. CUA guideline on adult overactive
bladder. Canadian Urological Association Journal. 2017;11(5):142. doi:10.5489/cuaj.4586
31

Irwin DE, Milsom I, Kopp Z, Abrams P, Artibani W, Herschorn S. Prevalence, Severity, and
Symptom Bother of Lower Urinary Tract Symptoms among Men in the EPIC Study: Impact of
Overactive Bladder. European Urology. 2009;56(1):14-20. doi:10.1016/j.eururo.2009.02.026
32

Fall M, Ohlsson BL, Carlsson C-A. The Neurogenic Overactive Bladder. Classification Based
on Urodynamics. British Journal of Urology. 1989;64(4):368-373. doi:10.1111/j.1464410x.1989.tb06045.x
33

Abrams P, Wein AJ. Introduction to the overactive bladder: From basic science to clinical
management. Urology. 1997;50(6):1-3. doi:10.1016/s0090-4295(97)00577-3
34

Tikkinen KA, Auvinen A. Does the Imprecise Definition of Overactive Bladder Serve
Commercial Rather than Patient Interests? European Urology. 2012;61(4):746-748.
30

doi:10.1016/j.eururo.2011.12.013
35

Zumrutbas AE, Bozkurt AI, Tas E, et al. Prevalence of lower urinary tract symptoms,
overactive bladder and urinary incontinence in western Turkey: Results of a population-based
survey. International Journal of Urology. 2014;21(10):1027-1033. doi:10.1111/iju.12519
36

Chapple CR, Wein AJ. The urgency of the problem and the problem of urgency in the
overactive bladder. BJU Int. 2005;95(3):274-275. doi: BJU5279
37

Anger JT, Nissim HA, Le TX, et al. Women's experience with severe overactive bladder
symptoms and treatment: Insight revealed from patient focus groups. Neurourol Urodyn.
2011;30(7):1295-1299. doi: 10.1002/nau.21004
38

Irwin DE, Milsom I, Chancellor MB, Kopp Z, Guan Z. Dynamic progression of overactive
bladder and urinary incontinence symptoms: A systematic review. Eur Urol. 2010;58(4):532543. doi: 10.1016/j.eururo.2010.06.007
39

Milsom I, Kaplan SA, Coyne KS, Sexton CC, Kopp ZS. Effect of bothersome overactive
bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in
the united states: Results from EpiLUTS. Urology. 2012;80(1):90-96. doi:
10.1016/j.urology.2012.04.004
40

Lee UJ, Scott VC, Rashid R, et al. Defining and managing overactive bladder: Disagreement
among the experts. Urology. 2013;81(2):257-262. doi: 10.1016/j.urology.2012.09.028
41

Robertson C, Link CL, Onel E, et al. The impact of lower urinary tract symptoms and
comorbidities on quality of life: The BACH and UREPIK studies. BJU Int. 2007;99(2):347-354.
doi: BJU6609
42

Fritel X, Panjo H, Varnoux N, Ringa V. The individual determinants of care-seeking among
middle-aged women reporting urinary incontinence: Analysis of a 2273-woman
cohort. Neurourol Urodyn. 2014;33(7):1116-1122. doi: 10.1002/nau.22461
43

Smith AL, Nissim HA, Le TX, et al. Misconceptions and miscommunication among aging
women with overactive bladder symptoms. Urology. 2011;77(1):55-59. doi:
10.1016/j.urology.2010.07.460
44

Welch LC, Taubenberger S, Tennstedt SL. Patients' experiences of seeking health care for
lower urinary tract symptoms. Res Nurs Health. 2011;34(6):496-507. doi: 10.1002/nur.20457
45

Botelho EM, Elstad EA, Taubenberger SP, Tennstedt SL. Moderating perceptions of bother
reports by individuals experiencing lower urinary tract symptoms. Qual Health Res.
2011;21(9):1229-1238. doi: 10.1177/1049732311405682

31

46

Diokno AC, Sand PK, Macdiarmid S, Shah R, Armstrong RB. Perceptions and behaviours of
women with bladder control problems. Fam Pract. 2006;23(5):568-577. doi: cml018
47

Shaw C, Tansey R, Jackson C, Hyde C, Allan R. Barriers to help seeking in people with
urinary symptoms. Fam Pract. 2001;18(1):48-52.
48

Helfand BT, Evans RM, Mcvary KT. A Comparison of the Frequencies of Medical Therapies
for Overactive Bladder in Men and Women: Analysis of More Than 7.2 Million Aging
Patients. European Urology. 2010;57(4):586-591. doi:10.1016/j.eururo.2009.12.025
49

Dmochowski RR, Newman DK. Impact of overactive bladder on women in the United
States:results of a national survey. Current Medical Research and Opinion. 2006;23(1):65-76.
doi:10.1185/030079907x159533
50

Link BG, Phelan JC. Stigma and its public health implications. The Lancet.
2006;367(9509):528-529. doi:10.1016/s0140-6736(06)68184-1
51

Mitteness LS, Barker JC. Stigmatizing a "Normal" Condition: Urinary Incontinence in Late
Life. Medical Anthropology Quarterly. 1995;9(2):188-210. doi:10.1525/maq.1995.9.2.02a00050
52

Benner JS, Becker R, Fanning K, et al. Bother related to bladder control and health care
seeking behavior in adults in the united states. J Urol. 2009;181(6):2591-2598. doi:
10.1016/j.juro.2009.02.018
53

Elstad EA, Taubenberger SP, Botelho EM, Tennstedt SL. Beyond incontinence: The stigma of
other urinary symptoms. J Adv Nurs. 2010;66(11):2460-2470. doi: 10.1111/j.13652648.2010.05422.x
54

Andersson G, Johansson JE, Sahlberg-Blom E, Pettersson N, Nilsson K. Urinary incontinence-why refraining from treatment? A population based study. Scand J Urol Nephrol.
2005;39(4):301-307. doi: K2762J85524536L0
55

Ricci JA, Baggish JS, Hunt TL, et al. Coping strategies and health care-seeking behavior in a
US national sample of adults with symptoms suggestive of overactive bladder. Clin Ther.
2001;23(8):1245-1259. doi: S0149-2918(01)80104-1
56

Hahn SR, Bradt P, Hewett KA, Ng DB. Physician-patient communication about overactive
bladder: Results of an observational sociolinguistic study. PLoS One. 2017;12(11):e0186122.
doi: 10.1371/journal.pone.0186122
57

Fix GM, Lukas CV, Bolton RE, et al. Patient-centred care is a way of doing things: How
healthcare employees conceptualize patient-centred care. Health Expectations. 2017;21(1):300307. doi:10.1111/hex.12615

32

58

Mckinlay JB, Link CL. Measuring the Urologic Iceberg: Design and Implementation of the
Boston Area Community Health (BACH) Survey. European Urology. 2007;52(2):389-396.
doi:10.1016/j.eururo.2007.03.013
59

Bates C, Whiteside CG, Turner-Warwick R. Synchronous Cine/pressure/flow/cystoUrethrography With Special Reference To Stress And Urge Incontinence. British Journal of
Urology. 1970;42(6):714-723. doi:10.1111/j.1464-410x.1970.tb06796.x
60

Digesu GA, Khullar V, Cardozo L, Salvatore S. Overactive bladder symptoms: Do we need
urodynamics? Neurourology and Urodynamics. 2003;22(2):105-108. doi:10.1002/nau.10099
61

Hashim H, Abrams P. Is the Bladder a Reliable Witness for Predicting Detrusor
Overactivity? The Journal of Urology. 2006;175(1). doi:10.1097/00005392-200601000-00053
62

Chuang FC, Liu HT, Wang LY, Kuo HC. Overactive bladder changes with time: A 5-year
longitudinal followup of changes in overactive bladder symptoms, urodynamic studies and
urinary nerve growth factor levels. J Urol. 2014;192(2):458-463. doi: 10.1016/j.juro.2014.02.091
63

Moga DC, Abner EL, Wu Q, Jicha GA. Bladder antimuscarinics and cognitive decline in
elderly patients. Alzheimers & Dementia: Translational Research & Clinical Interventions.
2017;3(1):139-148. doi:10.1016/j.trci.2017.01.003
64

Gray SL, Anderson ML, Dublin S, et al. Cumulative Use of Strong Anticholinergics and
Incident Dementia. JAMA Internal Medicine. 2015;175(3):401.
doi:10.1001/jamainternmed.2014.7663
65

Myint PK, Fox C, Kwok CS, Luben RN, Wareham NJ, Khaw K-T. Total anticholinergic
burden and risk of mortality and cardiovascular disease over 10 years in 21,636 middle-aged and
older men and women of EPIC-Norfolk prospective population study. Age and Ageing.
2014;44(2):219-225. doi:10.1093/ageing/afu185
66

Brown CT, Yap T, Cromwell DA, et al. Self management for men with lower urinary tract
symptoms: Randomised controlled trial. BMJ. 2007;334(7583):25. doi: bmj.39010.551319.AE
67 Dougherty MC, Dwyer JW, Pendergast JF, et al. A randomized trial of behavioral
management for continence with older rural women. Res Nurs Health. 2002;25(1):3-13. doi:
10.1002/nur.10016
68

Coyne KS, Sexton CC, Bell JA, et al. The prevalence of lower urinary tract symptoms (LUTS)
and overactive bladder (OAB) by racial/ethnic group and age: Results from OABPOLL. Neurourol Urodyn. 2013;32(3):230-237. doi: 10.1002/nau.22295
69

Nygaard I, Chai TC, Cundiff GW, et al. Summary of Research Recommendations From the
Inaugural American Urogynecologic Society Research Summit. Female Pelvic Medicine &
Reconstructive Surgery. 2011;17(1):4-7. doi:10.1097/spv.0b013e3182042168

33

70

Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive
bladder, incontinence and other lower urinary tract symptoms on quality of life, work
productivity, sexuality and emotional well-being in men and women: results from the EPIC
study. BJU International. 2008;101(11):1388-1395. doi:10.1111/j.1464-410x.2008.07601.x
71

Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder
in the united states. World J Urol. 2003;20(6):327-336. doi: 10.1007/s00345-002-0301-4
72

Buttorff C, Ruder T, Bauman M. Multiple Chronic Conditions in the United States. Santa
Monica, CA: RAND; 2017.
73

Pöyhönen A, Auvinen A, Häkkinen JT, Koskimäki J, Tammela TL. Population-level and
Individual-level Bother of Lower Urinary Tract Symptoms Among 30- to 80-year-old
Men. Urology. 2016;95:164-170. doi:10.1016/j.urology.2016.06.023
74

Ridder DD, Roumeguère T, Kaufman L. Overactive bladder symptoms, stress urinary
incontinence and associated bother in women aged 40 and above; a Belgian epidemiological
survey. International Journal of Clinical Practice. 2013;67(3):198-204. doi:10.1111/ijcp.12015
75

Irwin DE, Milsom I, Kopp Z, Abrams P. Symptom Bother and Health Care–Seeking Behavior
among Individuals with Overactive Bladder. European Urology. 2008;53(5):1029-1039.
doi:10.1016/j.eururo.2008.01.027
76

Coyne KS, Kvasz M, Ireland AM, Milsom I, Kopp ZS, Chapple CR. Urinary Incontinence and
its Relationship to Mental Health and Health-Related Quality of Life in Men and Women in
Sweden, the United Kingdom, and the United States. European Urology. 2012;61(1):88-95.
doi:10.1016/j.eururo.2011.07.049
77

Wolters R, Wensing M, Weel CV, Wilt GVD, Grol R. Lower urinary tract symptoms: social
influence is more important than symptoms in seeking medical care. BJU International.
2002;90(7):655-661. doi:10.1046/j.1464-410x.2002.02996.x
78

de Groat WCD, Griffiths D, Yoshimura N. Neural Control of the Lower Urinary
Tract. Comprehensive Physiology. 2014:327-396. doi:10.1002/cphy.c130056
79

Smith PP, Deangelis A, Kuchel GA. Detrusor expulsive strength is preserved, but
responsiveness to bladder filling and urinary sensitivity is diminished in the aging
mouse. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.
2012;302(5). doi:10.1152/ajpregu.00508.2011
80

Daly DM, Nocchi L, Liaskos M, Mckay NG, Chapple C, Grundy D. Age-related changes in
afferent pathways and urothelial function in the male mouse bladder. The Journal of Physiology.
2014;592(3):537-549. doi:10.1113/jphysiol.2013.262634
81

Aldamanhori R, Chapple CR. Underactive bladder, detrusor underactivity, definition,
symptoms, epidemiology, etiopathogenesis, and risk factors. Current Opinion in Urology.
2017;27(3):293-299. doi:10.1097/mou.0000000000000381
34

82

Chapple CR, Osman NI, Birder L, et al. The Underactive Bladder: A New Clinical
Concept? European Urology. 2015;68(3):351-353. doi:10.1016/j.eururo.2015.02.030
83

Siroky MB. The aging bladder. Rev Urol. 2004;6 Suppl 1(Suppl 1):S3–S7.

84

Suskind AM. The Aging Overactive Bladder: a Review of Aging-Related Changes from the
Brain to the Bladder. Current Bladder Dysfunction Reports. 2017;12(1):42-47.
doi:10.1007/s11884-017-0406-7
85

Smith PP. Aging and the underactive detrusor: A failure of activity or
activation? Neurourology and Urodynamics. 2009. doi:10.1002/nau.20765
86

Ates E, Ipekci T, Akin Y, Kizilay F, Kukul E, Guntekin E. Impact of sympathetic dysfunction
in the etiology of overactive bladder in women: A preliminary study. Neurourology and
Urodynamics. 2014;35(1):26-28. doi:10.1002/nau.22652
87

Chancellor MB. The overactive bladder progression to underactive bladder
hypothesis. International Urology and Nephrology. 2014;46(S1):23-27. doi:10.1007/s11255014-0778-y
88

Tam J, Cohen T, Kim J, Weissbart S. Insight Into the Central Control of Overactive Bladder
Symptoms by Functional Brain Imaging. Current Bladder Dysfunction Reports. 2018;13(2):3137. doi:10.1007/s11884-018-0464-5
89

Valentino RJ, Wood SK, Wein AJ, Zderic SA. The bladder–brain connection: putative role of
corticotropin-releasing factor. Nature Reviews Urology. 2010;8(1):19-28.
doi:10.1038/nrurol.2010.203
90

Smith PP, et al. Underactive bladder and detrusor underactivity represent different facets of
volume hyposensitivity and not impaired contractility. Bladder. 2015;2(2):e17.
91

Smith PP, Chalmers DJ, Feinn RS. Does defective volume sensation contribute to detrusor
underactivity? Neurourology and Urodynamics. 2014;34(8):752-756. doi:10.1002/nau.22653
92

Chang YH, Siu JJ, Hsiao PJ, Chang CH, Chou EC. Review of underactive bladder. J Formos
Med Assoc. 2018;117(3):178-184. doi: S0929-6646(17)30367-4
93

Cucchi A, Quaglini S, Rovereto B. Different evolution of voiding function in underactive
bladders with and without detrusor overactivity. J Urol. 2010;183(1):229–33.
94

Miyazato M, Yoshimura N, Chancellor MB. The other bladder syndrome: underactive
bladder. Rev Urol. 2013;15(1):11–22.

35

95

Osman NI, Chapple CR, Abrams P, et al. Detrusor Underactivity and the Underactive Bladder:
A New Clinical Entity? A Review of Current Terminology, Definitions, Epidemiology,
Aetiology, and Diagnosis. European Urology. 2014;65(2):389-398.
doi:10.1016/j.eururo.2013.10.015
96

Faraj K, Doo F, Boura J, Vereecke A, Chancellor MB. A cross-sectional study in the USA of
the epidemiology and quality of life of underactive bladder symptoms. International Urology
and Nephrology. 2016;48(11):1797-1802. doi:10.1007/s11255-016-1382-0

97

Ameda K, Sullivan MP, Bae RJ, Yalla SV. Urodynamic Characterization Of Nonobstructive
Voiding Dysfunction In Symptomatic Elderly Men. Journal of Urology. 1999;162(1):142-146.
doi:10.1097/00005392-199907000-00035
98

Birder L, Andersson K-E. Urothelial Signaling. Physiological Reviews. 2013;93(2):653-680.
doi:10.1152/physrev.00030.2012
99

Yoshida M, Homma Y, Inadome A, et al. Age-related changes in cholinergic and purinergic
neurotransmission in human isolated bladder smooth muscles. Experimental Gerontology.
2001;36(1):99-109. doi:10.1016/s0531-5565(00)00175-3
O’Reilly BA, Kosaka AH, Knight GF, et al. P2X Receptors And Their Role In Female
Idiopathic Detrusor Instability. Journal of Urology. 2002;167(1):157-164. doi:10.1016/s00225347(05)65403-1
100

101

Fry CH, Bayliss M, Young JS, Hussain M. Influence of age and bladder dysfunction on the
contractile properties of isolated human detrusor smooth muscle. BJU International.
2010;108(2b). doi:10.1111/j.1464-410x.2010.09845.x
102

Griffiths DJ, Fowler CJ. The micturition switch and its forebrain influences. Acta Physiol
(Oxf). 2013; 207:93–109
103

Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci.
2008;9(6):453–66.
104

Tadic SD, Griffiths D, Schaefer W, Murrin A, Clarkson B, Resnick NM. Brain activity
underlying impaired continence control in older women with overactive bladder. Neurourol
Urodyn. 2012;31(5): 652–8.

36

105

Smith PP, Kuchel GA, Griffiths D. Functional brain imaging and the neural basis for voiding
dysfunction in older adults. Clin Geriatr Med. 2015;31(4):549–65.
106

Tadic SD, Griffiths D, Schaefer W, Resnick NM. Abnormal connections in the supraspinal
bladder control network in women with urge urinary incontinence. NeuroImage.
2008;39(4):1647-1653. doi:10.1016/j.neuroimage.2007.10.059
107

Nardos R, Karstens L, Carpenter S, et al. Abnormal functional connectivity in women with
urgency urinary incontinence: Can we predict disease presence and severity in individual women
using Rs-fcMRI/. Neurourology and Urodynamics. 2015;35(5):564-573. doi:10.1002/nau.22767
108

Griffiths D, Tadic SD, Schaefer W, Resnick NM. Cerebral control of the bladder in normal
and urge-incontinent women. NeuroImage. 2007;37(1):1-7.
doi:10.1016/j.neuroimage.2007.04.061
109

Griffiths D, Derbyshire S, Stenger A, Resnick N. Brain Control Of Normal And Overactive
Bladder. Journal of Urology. 2005;174(5):1862-1867. doi:10.1097/01.ju.0000177450.34451.97
110

Griffiths DJ, Tadic SD, Schaefer W, Resnick NM. Cerebral control of the lower urinary tract:
How age-related changes might predispose to urge incontinence. NeuroImage. 2009;47(3):981986. doi:10.1016/j.neuroimage.2009.04.087
111

Arya NG, Weissbart SJ, Xu S, Bhavsar R, Rao H. Quantitative Changes in Cerebral Perfusion
during Urinary Urgency in Women with Overactive Bladder. BioMed Research International.
2017;2017:1-8. doi:10.1155/2017/2759035
112

Griffiths D, Tadic SD. Bladder control, urgency, and urge incontinence: Evidence from
functional brain imaging. Neurourology and Urodynamics. 2008;27(6):466-474.
doi:10.1002/nau.20549
113

Clapp WC, Rubens MT, Sabharwal J, Gazzaley A. Deficit in switching between functional
brain networks underlies the impact of multitasking on working memory in older
adults. Proceedings of the National Academy of Sciences. 2011;108(17):7212-7217.
doi:10.1073/pnas.1015297108
114

Bhopal, RS (2008). "Interrelated concepts in the epidemiology of disease: Natural history,
spectrum, iceberg, population patterns, and screening". Concepts of epidemiology: Integrating
the ideas, theories, principles, and methods of epidemiology (2nd ed.). Oxford: Oxford
University Press. doi:10.1093/acprof:oso/9780199543144.001.0001. ISBN 9780199543144.
115

Burgio KL, Locher JL, Goode PS, et al. Behavioral vs Drug Treatment for Urge Urinary
Incontinence in Older Women. Jama. 1998;280(23):1995. doi:10.1001/jama.280.23.1995

37

